Home › Funds › Cormorant Asset Management, LP › IBIO

Cormorant Asset Management, LP position in IBIO

IBIO INC · Health Care

Cormorant Asset Management, LP reported holding 3,570,000 shares of IBIO (IBIO INC) in its Q2 2026 13F filing — a position valued at US$6.2M, representing 0.32% of its reported portfolio and ranking #38 among its reported holdings. Cormorant Asset Management, LP first reported this position in Q2 2026.

Latest position (Q2 2026)3.57M sh
Reported value held$6.25M
Portfolio Weight0.32%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Cormorant Asset Management, LP's IBIO position evolved

Cormorant Asset Management, LP first disclosed a stake in IBIO in Q2 2026 at 3,570,000 shares (US$6.2M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 3.57M $6.25M New

About IBIO and 13F data

IBIO (IBIO INC) is a Health Care company. 44 other funds we track also report a position in IBIO — the largest reported positions include SILVERARC CAPITAL MANAGEMENT, LLC (US$6.2M), Frazier Life Sciences Management, L.P. (US$3.4M), Sio Capital Management, LLC (US$1.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBIO

All IBIO fund holders →

FAQ

How long has Cormorant Asset Management, LP held IBIO?

Cormorant Asset Management, LP has disclosed IBIO holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Cormorant Asset Management, LP's current position in IBIO?

As of Q2 2026, Cormorant Asset Management, LP holds 3.57M shares of IBIO (IBIO INC), valued at $6.25M, representing 0.32% of its reported portfolio and ranking #38.

Has Cormorant Asset Management, LP been buying or selling IBIO?

In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP newly opened its position in IBIO.

Which other funds hold IBIO?

Other major institutional holders of IBIO include SILVERARC CAPITAL MANAGEMENT, LLC, Frazier Life Sciences Management, L.P., Sio Capital Management, LLC, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.